ATYR FY 2025 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$93M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$190,000-19.1% YoY

Gross Profit

-$1M-717.4% margin

Operating Income

-$78M-40856.3% margin

Net Income

-$74M-39009.5% margin

EPS (Diluted)

$-0.80

Cash Flow

Operating Cash Flow

-$62M

Free Cash Flow

-$62M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$93M

Total Liabilities

$27M

Stockholders' Equity

$67M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$190,000	$235,000	-19.1%
Gross Profit	-$1M	$235,000	-680.0%
Operating Income	-$78M	-$68M	-14.3%
Net Income	-$74M	-$64M	-15.8%